Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses.

ABSTRACT:

SUBMITTER: Brown JR 

PROVIDER: S-EPMC7954938 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature